These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3628822)

  • 21. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.
    Butturini AM; Jacob M; Aguajo J; Vander-Walde NA; Villablanca J; Jubran R; Erdreich-Epstein A; Marachelian A; Dhall G; Finlay JL
    Cancer; 2009 Jul; 115(13):2956-63. PubMed ID: 19402050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of childhood brain tumors in Serbia.
    Nikitovic M; Golubicic I; Pekmezovic T; Grujicic D; Plesinac-Karapandzic V
    J BUON; 2011; 16(2):290-6. PubMed ID: 21766500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy.
    Valteau-Couanet D; Fillipini B; Benhamou E; Grill J; Kalifa C; Couanet D; Habrand JL; Hartmann O
    Bone Marrow Transplant; 2005 Dec; 36(11):939-45. PubMed ID: 16184181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of adjuvant chemotherapy in the treatment of medulloblastoma in children].
    Sachivko NV; Konoplia NE; Petrovich SV; Sharak EV
    Vopr Onkol; 2002; 48(3):318-21. PubMed ID: 12455354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracranial ependymomas: treatment results and prognostic factors.
    Zorlu AF; Atahan IL; Akyol FH; Gürkaynak M; Ozyar E
    Radiat Med; 1994; 12(6):269-72. PubMed ID: 7724818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors.
    Bobola MS; Finn LS; Ellenbogen RG; Geyer JR; Berger MS; Braga JM; Meade EH; Gross ME; Silber JR
    Clin Cancer Res; 2005 Oct; 11(20):7405-14. PubMed ID: 16243814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cochlear implantation following treatment for medulloblastoma.
    Roland JT; Cosetti M; Liebman T; Waltzman S; Allen JC
    Laryngoscope; 2010 Jan; 120(1):139-43. PubMed ID: 19693928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medulloblastoma in Nordic children. A population-based epidemiologic study with long-term follow-up of the survivors.
    Acta Paediatr Scand Suppl; 1990; 371():1-27. PubMed ID: 2085120
    [No Abstract]   [Full Text] [Related]  

  • 29. Severe encephalopathy after high-dose chemotherapy with autologous stem cell support for brain tumours.
    van den Berkmortel F; Gidding C; De Kanter M; Punt CJ
    Anticancer Res; 2006; 26(1B):729-33. PubMed ID: 16739345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy].
    Röttinger EM
    Strahlenther Onkol; 1995 Apr; 171(4):247-8. PubMed ID: 7740416
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapy of medulloblastoma and ependymoma in childhood].
    Terheggen HG
    Dtsch Med Wochenschr; 1977 Jun; 102(24):899-901. PubMed ID: 872757
    [No Abstract]   [Full Text] [Related]  

  • 32. [Medulloblastoma: analysis of 14 cases treated at the J. Bordet Institute and literature review].
    Ismaili K; Sariban E; Otten J; Regnier R
    Rev Med Brux; 1992 Mar; 13(3):51-60. PubMed ID: 1561501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Medulloblastoma in children. Current treatments and future perspectives].
    Gentet JC; Genitori L; Mancini J; Bernard JL; Coze C; Nicolas C; Raybaud C
    Ann Pediatr (Paris); 1991 Mar; 38(3):137-41. PubMed ID: 2039181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I).
    Tait DM; Thornton-Jones H; Bloom HJ; Lemerle J; Morris-Jones P
    Eur J Cancer; 1990 Apr; 26(4):464-9. PubMed ID: 2141512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Adoptive immunotherapy in patients with medulloblastoma by LAK cells].
    Shimizu K; Tamura K; Yamada M; Okamoto Y; Miyao Y; Park K; Matsui Y; Hayakawa T; Takimoto H; Mogami H
    No To Shinkei; 1989 Oct; 41(10):991-5. PubMed ID: 2605046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Usefulness and problems of high dose chemotherapy using CBDCA, VP-16, and MCNU with peripheral blood stem cell transplantation in pediatric malignant brain tumors].
    Sasajima T; Mineura K; Kowada M; Watanabe A; Takeda O
    No To Shinkei; 1996 Jul; 48(7):653-8. PubMed ID: 8753001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experiences in treating medulloblastoma at the University of Minnesota hospitals.
    Smith CE; Long DM; Jones TK; Levitt SH
    Radiology; 1973 Oct; 109(1):179-82. PubMed ID: 4544581
    [No Abstract]   [Full Text] [Related]  

  • 38. High-dose chemotherapy with autologous stem cell rescue for malignant brain tumors.
    Dunkel IJ
    Cancer Invest; 2000; 18(5):492-3. PubMed ID: 10834034
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of a child's sex on medulloblastoma outcome.
    Weil MD; Lamborn K; Edwards MS; Wara WM
    JAMA; 1998 May; 279(18):1474-6. PubMed ID: 9600483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain tumors. Challenges and directions.
    Kun LE
    Pediatr Clin North Am; 1997 Aug; 44(4):907-17. PubMed ID: 9286291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.